Health inspection·September 18, 2023

F 0760 Ensure that residents are free from significant medication errors. Level of Harm - Minimal harm or potential for actual harm Based on record review, staff and resident interviews, review of facility policies, the facility failed to ensure medications were administered as scheduled for 1(Resident #999) of 3 residents reviewed for medication administration. The failure to administer medications accurately places the residents at risk for adverse health consequences, sub-optimal therapy, or pharmacological effects. Residents Affected - Few The findings included: The facility policy Administering Medications (revised 4/19) documented, Medications are administered in a safe and timely manner, and as prescribed . Medications are administered in accordance with prescriber orders, including any required time frames. If a drug is withheld, refused or given at a time other than the scheduled time, the individual administering the medication shall initial and circle the Medication Administration record (MAR) space provided for that drug and dose. Review of the clinical record revealed Resident #999 had an admission date of 11/22/22 with diagnoses including Parkinson's disease and history of falling. The Quarterly Minimum Data Set (standardized assessment tool that measures health status in nursing home residents) with an assessment reference date of 8/26/23 documented Resident #999's cognitive skills for daily decision making were intact. On 9/18/23 at 9:37 a.m., Resident #999 said there are days he does not receive his scheduled Parkinson's medication. The resident said he needs the medication and without it he gets stiff and rigid and has difficulty moving. The record showed a physician order dated 5/16/23 documented Rytary (Carbidopa-Levodopa) oral capsule extended release 23.75-95 milligrams (mg), give 3 capsules by mouth four times a day for Parkinson's. Give before meals. The medication was scheduled for administration at 6:30 a.m., 11:30 a.m., 4:30 p.m., and 10:30 p.m. Review of the Medication Administration Record (MAR) for the month of August 2023, showed no documentation Resident #999 received the scheduled dose of Rytary extended release on 8/13/23, 8/16/23, and 8/23/23 at 6:30 a.m., and on 8/29/23 at 4:30 p.m. The MAR did not document why the medication was omitted. Review of the MAR for the month of September 2023 showed no documentation Resident #999 received the scheduled dose of Rytary extended release on 9/6/23 and 9/7/23 at 6:30 a.m. There was no documentation the medication was administered on 9/17/23 at 4:30 p.m., and 10:30 p.m. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 106032 Printed: 05/28/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 106032 B. Wing A. Building (X3) DATE SURVEY COMPLETED 09/18/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Aviata at Sarasota 1507 S Tuttle Ave Sarasota, FL 34239 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)